Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00758563 · ClinicalTrials.gov registry record · Phase 3
Train New Examiners Via Modified Gingival Margin Plaque
A Phase 3 study, sponsored by Colgate Palmolive.
- Completed
- Registry status
- Phase 3
- Development phase
- 15
- Enrollment target
NCT00758563 is a Phase 3 study that has completed, run by Colgate Palmolive. The registered enrollment target is 15 participants.
The verdict
NCT00758563, a Phase 3 study, has completed, sponsored by Colgate Palmolive.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 15 participants
- Enrollment target
Study Summary
The purpose of this study is to train new examiners while testing two commercial products using our standard one-day brushing study regimen by measuring gingival margin plaque index.
Interventions
- DRUG Fluoride
- DRUG Triclosan/Fluoride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2008-03 |
| Est. Completion | 2008-04 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00758563
The ClinicalTrials.gov registry entry for NCT00758563 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Colgate Palmolive, which has 51 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Fluoride is the first listed.
NCT00758563 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00758563 about?
NCT00758563 is a clinical study titled "Train New Examiners Via Modified Gingival Margin Plaque". The purpose of this study is to train new examiners while testing two commercial products using our standard one-day brushing study regimen by measuring gingival margin plaque index.
What is the current status of trial NCT00758563?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 15 participants. The study started on 2008-03. Estimated completion is 2008-04.
What interventions are being tested in trial NCT00758563?
The interventions under investigation include: Fluoride (DRUG), Triclosan/Fluoride (DRUG).
Who is sponsoring clinical trial NCT00758563?
This trial is sponsored by Colgate Palmolive, which has 51 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.